MarketResearch.biz delivers in-depth insights on the global nasal drug delivery systems market in its upcoming report titled, “Global Nasal Drug Delivery Systems Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global drugs market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global nasal drug delivery systems market report has been segmented on the basis of dosage form, system type, therapeutic application, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analysed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Administration of drugs through nasal route, for achieving rapid efficacy of drugs is known as nasal drug delivery systems.
Various advantages associated with use of nasal drug delivery systems such as rapid absorption, higher bioavailability, reduced risk of over dose and improved patient compliance is a major factor expected to support the growth of the global nasal drug delivery systems market over the forecast period. Companies focusing on development of innovative and novel nasal drug delivery systems is expected to fuel growth of the global nasal drug delivery systems market over the forecast period. In addition, increasing number of product approvals and subsequent launch of the same, with a view to gain competitive edge is expected to support growth of the market.
Based on dosage form, the global nasal drug delivery systems market is segmented based sprays, drops & liquids, powders, and gels. The nasal sprays segment is expected to account for major revenue share and is expected to maintain market dominance over the forecast period.
North America market dominates the global nasal drug delivery systems market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to presence of significant market players and increasing number of product approval in the region. Europe accounts for second-largest revenue share contribution to the global nasal drug delivery systems market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. Increasing prevalence of respiratory diseases is a major factor expected to support growth of the market in the region over the forecast period.
Target audience for the global nasal drug delivery systems market includes industry associations, nasal drug delivery systems manufacturers, hospitals, research institutes, nasal delivery supplier, government and research organizations, industrial and association bodies, and others.
Global nasal drug delivery systems market segmentation, by dosage form:
- Drops & Liquids
Global nasal drug delivery systems market segmentation, by system type:
- Unit Dose
Global nasal drug delivery systems market segmentation, by therapeutic application
- Allergic and Non-Allergic Rhinitis
- Nasal Congestion
Global nasal drug delivery systems market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Merck & Co., Inc.
- Novartis AG
- Glaxosmithkline PLC
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Astrazeneca PLC
- Valeant Pharmaceuticals International, Inc.
- Becton, Dickinson and Company
- AptarGroup, Inc.
- Aegis Therapeutics LLC.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!